0001179110-20-007780.txt : 20200625
0001179110-20-007780.hdr.sgml : 20200625
20200625182218
ACCESSION NUMBER: 0001179110-20-007780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brophy Michael Burkes
CENTRAL INDEX KEY: 0001697362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 20990406
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-23
0
0001604821
Natera, Inc.
NTRA
0001697362
Brophy Michael Burkes
C/O NATERA, INC., 201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
0
1
0
0
Chief Financial Officer
Common Stock
2020-06-23
4
M
0
12500
A
54166
D
Common Stock
2020-06-24
4
S
0
5049
45.4706
D
49117
D
Common Stock
2020-06-24
4
S
0
4572
46.0188
D
44545
D
Common Stock
2020-06-24
4
S
0
400
46.64
D
44145
D
Restricted Stock Units
2029-06-23
4
M
0
12500
0
D
Common Stock
12500
37500
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting September 19, 2019.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.47 to $45.4975 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.47 to $46.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 23, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.
/s/ Tami Chen, attorney-in-fact
2020-06-25